skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: CD147 deficiency blocks IL-8 secretion and inhibits lung cancer-induced osteoclastogenesis

Abstract

Bone is a frequent target of lung cancer metastasis, which is associated with significant morbidity and poor prognosis; however, the molecular basis of this process is still unknown. This study investigated the role of extracellular matrix metalloproteinase inducer (also known as cluster of differentiation (CD)147) in osteoclastogenesis resulting from bone metastasis, based on the enrichment of this glycoprotein on the surface of many malignant bone tumors. RNA interference was used to silence CD147 expression in A549 human lung cancer cells. Compared with conditioned medium (CM) from control cells (A549-CM), CM from CD147-deficient cells (A549-si-CM) suppressed receptor activator of nuclear factor κB ligand-stimulated osteoclastogenesis in RAW 264.7 cells and bone marrow-derived macrophages. The mRNA levels of osteoclast-specific genes such as tartrate-resistant acid phosphatase, calcitonin receptor, and cathepsin K were also reduced in the presence of A549-si-CM. CD147 knockdown in A549 cells decreased interleukin (IL)-8mRNA and protein expression. IL-8 is present in large amounts in A549-CM and mimicked its inductive effect on osteoclastogenesis; this was reversed by depletion of IL-8 from the medium. Taken together, these results indicate that CD147 promotes lung cancer-induced osteoclastogenesis by modulating IL-8 secretion, and suggest that CD147 is a potential therapeutic target for cancer-associated bone resorption inmore » lung cancer patients. - Highlights: • Bone loss frequently results from lung cancer metastasis. • Cluster of differentiation (CD)147 was depleted in A549 lung adenocarcinoma cells. • RAW 264.7 cell osteoclastogenesis was blocked by medium from CD147-deficient cells. • Interleukin (IL)-8 level was reduced in the conditioned medium. • Osteoclastogenesis induced by lung tumor cells requires CD147-mediated IL-8 release.« less

Authors:
; ; ; ; ;
Publication Date:
OSTI Identifier:
22458512
Resource Type:
Journal Article
Resource Relation:
Journal Name: Biochemical and Biophysical Research Communications; Journal Volume: 458; Journal Issue: 2; Other Information: Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; ACID PHOSPHATASE; ALBUMINS; BONE MARROW; CALCITONIN; CARCINOMAS; CATHEPSINS; GENES; GLYCOPROTEINS; GROWTH FACTORS; IMMUNOGLOBULINS; LIGANDS; LUNGS; MACROPHAGES; MESSENGER-RNA; METASTASES; PATIENTS; RADIOPROTECTIVE SUBSTANCES; RECEPTORS; SECRETION; TUMOR CELLS

Citation Formats

Wang, Hongkai, Zhuo, Yunyun, Hu, Xu, Shen, Weiwei, Zhang, Ying, and Chu, Tongwei, E-mail: chtw@sina.com. CD147 deficiency blocks IL-8 secretion and inhibits lung cancer-induced osteoclastogenesis. United States: N. p., 2015. Web. doi:10.1016/J.BBRC.2015.01.097.
Wang, Hongkai, Zhuo, Yunyun, Hu, Xu, Shen, Weiwei, Zhang, Ying, & Chu, Tongwei, E-mail: chtw@sina.com. CD147 deficiency blocks IL-8 secretion and inhibits lung cancer-induced osteoclastogenesis. United States. doi:10.1016/J.BBRC.2015.01.097.
Wang, Hongkai, Zhuo, Yunyun, Hu, Xu, Shen, Weiwei, Zhang, Ying, and Chu, Tongwei, E-mail: chtw@sina.com. Fri . "CD147 deficiency blocks IL-8 secretion and inhibits lung cancer-induced osteoclastogenesis". United States. doi:10.1016/J.BBRC.2015.01.097.
@article{osti_22458512,
title = {CD147 deficiency blocks IL-8 secretion and inhibits lung cancer-induced osteoclastogenesis},
author = {Wang, Hongkai and Zhuo, Yunyun and Hu, Xu and Shen, Weiwei and Zhang, Ying and Chu, Tongwei, E-mail: chtw@sina.com},
abstractNote = {Bone is a frequent target of lung cancer metastasis, which is associated with significant morbidity and poor prognosis; however, the molecular basis of this process is still unknown. This study investigated the role of extracellular matrix metalloproteinase inducer (also known as cluster of differentiation (CD)147) in osteoclastogenesis resulting from bone metastasis, based on the enrichment of this glycoprotein on the surface of many malignant bone tumors. RNA interference was used to silence CD147 expression in A549 human lung cancer cells. Compared with conditioned medium (CM) from control cells (A549-CM), CM from CD147-deficient cells (A549-si-CM) suppressed receptor activator of nuclear factor κB ligand-stimulated osteoclastogenesis in RAW 264.7 cells and bone marrow-derived macrophages. The mRNA levels of osteoclast-specific genes such as tartrate-resistant acid phosphatase, calcitonin receptor, and cathepsin K were also reduced in the presence of A549-si-CM. CD147 knockdown in A549 cells decreased interleukin (IL)-8mRNA and protein expression. IL-8 is present in large amounts in A549-CM and mimicked its inductive effect on osteoclastogenesis; this was reversed by depletion of IL-8 from the medium. Taken together, these results indicate that CD147 promotes lung cancer-induced osteoclastogenesis by modulating IL-8 secretion, and suggest that CD147 is a potential therapeutic target for cancer-associated bone resorption in lung cancer patients. - Highlights: • Bone loss frequently results from lung cancer metastasis. • Cluster of differentiation (CD)147 was depleted in A549 lung adenocarcinoma cells. • RAW 264.7 cell osteoclastogenesis was blocked by medium from CD147-deficient cells. • Interleukin (IL)-8 level was reduced in the conditioned medium. • Osteoclastogenesis induced by lung tumor cells requires CD147-mediated IL-8 release.},
doi = {10.1016/J.BBRC.2015.01.097},
journal = {Biochemical and Biophysical Research Communications},
number = 2,
volume = 458,
place = {United States},
year = {Fri Mar 06 00:00:00 EST 2015},
month = {Fri Mar 06 00:00:00 EST 2015}
}